Search





Search





Markets
/
Stocks
/
toi
/

Oncology Institute Inc

TOI

Add to Watchlist

4.860USD

-0.210-4.14%

Close 07-31 16:00（ET）Quotes delayed by 15 min

485.87MMarket Cap

LossP/E TTM

Oncology Institute Inc

4.860

-0.210-4.14%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

TOI Cash Flow Statement

You can access the annual and quarterly cash flow statements of Oncology Institute Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q1

FY2020Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

55.59%-2.21M

-22.77%3.23M

-1642.12%-12.63M

34.85%-10.20M

68.60%-4.99M

207.53%4.19M

109.86%819.00K

-77.89%-15.66M

-2.79%-15.88M

72.80%-3.89M

59.39%-8.31M

15.18%-8.80M

9.00%-15.45M

38.66%-14.31M

---20.46M

---10.38M

-3759.70%-16.98M

-2564.73%-23.34M

--464.00K

---875.71K

Net income from continuing operations

87.28%-2.49M

43.04%-7.51M

-2.43%-16.50M

-9.88%-17.01M

1.53%-19.59M

29.71%-13.18M

7.50%-16.11M

8.39%-15.48M

33.70%-19.89M

-70.38%-18.75M

-551.42%-17.42M

-209.87%-16.90M

-255.54%-30.00M

-8.38%-11.01M

---2.67M

---5.45M

2036.35%19.29M

-110.78%-10.16M

---996.00K

---4.82M

Operating gains losses

-9.42%1.62M

-4.39%1.63M

9.54%1.72M

18.91%1.80M

19.81%1.78M

8.24%1.71M

-7.36%1.57M

14.22%1.52M

-91.79%1.49M

-85.84%1.58M

49.74%1.70M

21.04%1.33M

1737.49%18.14M

1111.19%11.14M

--1.13M

--1.10M

27.03%987.00K

16.41%919.42K

--777.00K

--789.78K

Deferred tax

----

--0.00

---32.00K

----

100.00%0.00

-100.00%0.00

100.00%0.00

71.75%-126.00K

53.85%80.00K

91.84%-4.00K

-114.44%-26.00K

-119.43%-446.00K

--52.00K

---49.00K

-18.55%180.00K

604.49%2.30M

--221.00K

---455.10K

Other non-cash items

-75.15%1.21M

-24.36%1.21M

-23.85%1.17M

145.27%3.53M

294.66%4.87M

-2.98%1.59M

-37.84%1.54M

64.91%1.44M

104.47%1.23M

158.58%1.64M

146.12%2.48M

730.48%872.00K

2182.76%604.00K

102.26%635.00K

--1.01M

--105.00K

-261.11%-29.00K

-760.95%-28.10M

--18.00K

--4.25M

Change in working capital

-70.34%928.00K

-39.90%7.65M

-153.84%-6.17M

3.55%-3.29M

214.53%3.13M

97.55%12.73M

1131.77%11.46M

-289.12%-3.41M

42.81%-2.73M

223.53%6.45M

85.38%-1.11M

564.58%1.80M

40.24%-4.78M

58.85%-5.22M

---7.60M

--271.00K

-2088.31%-7.99M

-1610.53%-12.68M

--402.00K

---741.26K

-Change in receivables

86.80%-130.00K

-89.35%658.00K

-720.08%-4.04M

-272.48%-8.21M

93.93%-985.00K

54.24%6.18M

75.90%-493.00K

1040.91%4.76M

-172.46%-16.22M

178.12%4.01M

66.74%-2.05M

86.26%-506.00K

-26.58%-5.95M

-435.78%-5.13M

---6.15M

---3.68M

-724.91%-4.70M

157.17%1.53M

---570.00K

---2.67M

-Change in inventory

-226.80%-7.42M

2895.52%2.01M

-354.61%-3.10M

-1599.14%-3.48M

-206.83%-2.27M

104.55%67.00K

20366.67%1.22M

112.12%232.00K

313.90%2.12M

-272.77%-1.47M

99.29%-6.00K

-377.31%-1.91M

25.45%-993.00K

269.62%852.00K

---851.00K

---401.00K

-13420.00%-1.33M

-258.32%-502.31K

--10.00K

--317.28K

-Change in prepaid expenses

113.36%144.00K

-80.57%230.00K

453.00%553.00K

346.83%2.33M

-71.38%-1.08M

196.00%1.18M

-93.89%100.00K

-53.27%521.00K

-2520.83%-629.00K

-45.73%400.00K

-31.59%1.64M

60.20%1.11M

-105.26%-24.00K

108.08%737.00K

--2.39M

--696.00K

714.29%456.00K

-2158.34%-9.12M

--56.00K

---403.98K

-Change in other current assets

-100.97%-14.00K

-101.54%-20.00K

100.00%0.00

-451.71%-1.44M

-17.24%1.45M

-4.20%1.30M

-107.35%-97.00K

-75.81%410.00K

29.33%1.75M

-18.65%1.36M

-10.45%1.32M

44.38%1.69M

45.01%1.35M

-81.52%1.67M

--1.47M

--1.17M

338.72%931.00K

101208.57%9.02M

---390.00K

---8.93K

-Change in other current liabilities

-100.00%0.00

8300.00%84.00K

105.41%2.00K

-15.29%-98.00K

101.22%1.00K

102.04%1.00K

50.00%-37.00K

86.64%-85.00K

-125.95%-82.00K

41.67%-49.00K

93.12%-74.00K

-31900.00%-636.00K

--316.00K

-130.85%-84.00K

---1.07M

--2.00K

-100.00%0.00

213.05%272.33K

--362.00K

--86.99K

Cash from non-recurring investing activities

Cash from operating activities

55.59%-2.21M

-22.77%3.23M

-1642.12%-12.63M

34.85%-10.20M

68.60%-4.99M

207.53%4.19M

109.86%819.00K

-77.89%-15.66M

-2.79%-15.88M

72.80%-3.89M

59.39%-8.31M

15.18%-8.80M

9.00%-15.45M

38.66%-14.31M

---20.46M

---10.38M

-3759.70%-16.98M

-2564.73%-23.34M

--464.00K

---875.71K

Investing cash flow

Net cash from continuing investing activities

415.84%1.04M

-39.60%1.06M

250.25%604.00K

-33.84%1.21M

-66.89%202.00K

103.83%1.75M

-143.23%-402.00K

94.88%1.83M

-66.83%610.00K

-56.84%861.00K

-21.85%930.00K

-30.18%937.00K

83.53%1.84M

128.95%2.00M

--1.19M

--1.34M

61.87%1.00M

143.09%871.37K

--619.00K

--358.46K

Capital expenditures

217.68%1.04M

-39.60%1.06M

--604.00K

-33.84%1.21M

-46.23%328.00K

103.83%1.75M

----

94.88%1.83M

-66.83%610.00K

-56.84%861.00K

-21.85%930.00K

-30.18%937.00K

83.53%1.84M

128.95%2.00M

--1.19M

--1.34M

61.87%1.00M

143.09%871.37K

--619.00K

--358.46K

Net cash flow from disposal of fixed assets

415.84%1.04M

-39.60%1.06M

250.25%604.00K

-33.84%1.21M

-66.89%202.00K

103.83%1.75M

-143.23%-402.00K

94.88%1.83M

-66.83%610.00K

-56.84%861.00K

-21.85%930.00K

-30.18%937.00K

83.53%1.84M

128.95%2.00M

--1.19M

--1.34M

61.87%1.00M

143.09%871.37K

--619.00K

--358.46K

Net cash flow from intangible asset transactions

----

--0.00

----

--0.00

----

--0.00

Net cash flow from business transactions

----

100.00%0.00

--0.00

----

66.81%-156.00K

-100.00%0.00

51.79%-4.30M

----

94.32%-470.00K

--813.00K

---8.92M

100.00%0.00

---8.28M

---827.00K

--0.00

Net cash flow from investment products

----

--0.00

-100.00%0.00

15.75%10.00M

-33.95%20.00M

-1.20%20.00M

142.44%12.64M

109.89%8.64M

--30.28M

--20.24M

---29.79M

---87.34M

----

Net cash flow from other investing activities

--0.00

----

--0.00

----

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

-415.84%-1.04M

39.60%-1.06M

-105.81%-604.00K

-106.65%-1.21M

-101.04%-202.00K

-115.09%-1.75M

34.93%10.40M

-27.43%18.18M

5.36%19.39M

136.05%11.63M

108.79%7.71M

344.07%25.05M

1936.43%18.40M

-252.48%-32.26M

---87.72M

---10.26M

30.71%-1.00M

-2452.83%-9.15M

---1.45M

---358.46K

Financing cash flow

Cash flow from continuous financing activities

99.41%-28.00K

2376.83%3.73M

4462.14%10.60M

191.43%1.96M

-405.33%-4.74M

90.79%-164.00K

67.86%-243.00K

17.45%-2.15M

45.11%-938.00K

-110.27%-1.78M

-100.72%-756.00K

75.66%-2.60M

-3.14%-1.71M

-100.62%-847.00K

--105.39M

---10.69M

-107.40%-1.66M

280735.25%136.13M

--22.40M

---48.51K

Net cash flow from debt Issuance/repayment

99.96%-9.00K

10.00%-9.00K

27.27%-8.00K

-11.11%-10.00K

-222233.33%-20.01M

0.00%-10.00K

-10.00%-11.00K

85.71%-9.00K

50.00%-9.00K

47.37%-10.00K

-100.01%-10.00K

-384.62%-63.00K

-38.46%-18.00K

99.63%-19.00K

--106.32M

---13.00K

-100.54%-13.00K

-5137.65%-5.13M

--2.40M

---98.01K

Net cash flow from common stock issuance/repurchase

----

--0.00

100.00%0.00

----

--0.00

---125.00K

90.07%-894.00K

----

--0.00

---9.00M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--20.00M

--0.00

Proceeds from stock option exercised by employees

-84.67%21.00K

--3.96M

--10.31M

110050.00%2.20M

87.67%137.00K

-100.00%0.00

--2.00K

--73.00K

-74.43%113.00K

-83.54%13.00K

----

--442.00K

--79.00K

--337.00K

----

--50.00K

Proceeds from issuance of warrants

----

--132.00K

--385.00K

----

Net cash flow from other financing activities

-100.26%-40.00K

-127.27%-350.00K

63.79%-84.00K

89.25%-230.00K

1610.28%15.13M

91.83%-154.00K

63.41%-232.00K

-30.17%-2.14M

40.75%-1.00M

-48.35%-1.88M

37.10%-634.00K

18.17%-1.64M

-2.86%-1.69M

-100.90%-1.27M

---1.01M

---2.01M

---1.64M

28252300.00%141.26M

--0.00

---500.00

Net cash from non-recurrent financing activities

Net cash from financing activities

99.41%-28.00K

2376.83%3.73M

4462.14%10.60M

191.43%1.96M

-405.33%-4.74M

90.79%-164.00K

67.86%-243.00K

17.45%-2.15M

45.11%-938.00K

-110.27%-1.78M

-100.72%-756.00K

75.66%-2.60M

-3.14%-1.71M

-100.62%-847.00K

--105.39M

---10.69M

-107.40%-1.66M

280735.25%136.13M

--22.40M

---48.51K

Net cash flow

Beginning cash balance

-32.42%33.56M

-100.00%0.00

-16.84%30.29M

10.22%39.74M

48.32%49.67M

72.15%47.40M

26.07%36.42M

136.43%36.05M

139.03%33.49M

-55.17%27.54M

-55.00%28.89M

-84.04%15.25M

-87.84%14.01M

432.63%61.42M

--64.21M

--95.53M

1820.21%115.17M

58.40%11.53M

--6.00M

--7.28M

Current period cash flow changes

66.92%-3.29M

160.56%5.91M

-123.99%-2.63M

-2660.16%-9.45M

-486.83%-9.93M

-61.92%2.27M

908.99%10.98M

-97.30%369.00K

107.02%2.57M

112.56%5.95M

51.24%-1.36M

143.55%13.64M

106.31%1.24M

-145.75%-47.41M

---2.78M

---31.33M

-191.72%-19.64M

8180.08%103.64M

--21.41M

---1.28M

Ending cash balance

-23.80%30.28M

-88.11%5.91M

-41.65%27.66M

-16.84%30.29M

10.22%39.74M

48.32%49.67M

72.15%47.40M

26.07%36.42M

136.43%36.05M

139.03%33.49M

-55.17%27.54M

-55.00%28.89M

-84.04%15.25M

-87.84%14.01M

--61.42M

--64.21M

248.51%95.53M

1820.21%115.17M

--27.41M

--6.00M

Free cash flow

38.73%-3.26M

-10.61%2.17M

-1715.87%-13.23M

34.75%-11.41M

67.77%-5.32M

151.14%2.43M

108.86%819.00K

-79.53%-17.49M

4.62%-16.49M

70.85%-4.75M

57.32%-9.24M

16.90%-9.74M

3.85%-17.29M

32.63%-16.31M

---21.65M

---11.72M

-11501.94%-17.98M

-1861.37%-24.21M

---155.00K

---1.23M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Oncology Institute Inc Generate?



Oncology Institute Inc generated -24.59M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Oncology Institute Inc's Operating Cash Flow Change Year Over Year?



Oncology Institute Inc's operating cash flow increased by 7.35% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Oncology Institute Inc Spend on Capital Expenditures?



Oncology Institute Inc spent 3.20M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Oncology Institute Inc's Financing Cash Flow Changed?



Oncology Institute Inc used 11.56M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TOI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Oncology Institute Inc’s free cash flow in the latest quarter?



Free cash flow was -27.79M reflecting a 8.38% change from the previous year.